Phase I trial of LCT-Siro (sirolimus)
Latest Information Update: 11 Mar 2013
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery restenosis; Polycystic kidney disease; Renal transplant rejection
- Focus Adverse reactions
- Sponsors Veloxis Pharmaceuticals
- 04 Dec 2007 New trial record.